Wholegrain barley β-glucan fermentation does not improve glucose tolerance in rats fed a high-fat diet

Nutr Res. 2015 Feb;35(2):162-8. doi: 10.1016/j.nutres.2014.12.006. Epub 2014 Dec 31.

Abstract

Fermentation of oat and barley β-glucans is believed to mediate in part their metabolic health benefits, but the exact mechanisms remain unclear. In this study, we sought to test the hypothesis that barley β-glucan fermentation raises circulating incretin hormone levels and improves glucose control, independent of other grain components. Male Sprague-Dawley rats (n = 30) were fed a high-fat diet for 6 weeks and then randomly allocated to 1 of 3 dietary treatments for 2 weeks. The low- (LBG, 0% β-glucan) and high- (HBG, 3% β-glucan) β-glucan diets contained 25% wholegrain barley and similar levels of insoluble dietary fiber, available carbohydrate, and energy. A low-fiber diet (basal) was included for comparison. Immediately prior to the dietary intervention, gastric emptying rate (using the (13)C-octanoic breath test) and postprandial glycemic response of each diet were determined. At the end of the study, circulating gut hormone levels were determined; and a glucose tolerance test was performed. The rats were then killed, and indices of cecal fermentation were assessed. Diet did not affect live weight; however, the HBG diet, compared to basal and LBG, reduced food intake, tended to slow gastric emptying, increased cecal digesta mass and individual and total short-chain fatty acid pools, and lowered digesta pH. In contrast, circulating levels of glucose, insulin, gastric-inhibitory peptide, and glucagon-like peptide-1, and glucose tolerance were unaffected by diet. In conclusion, wholegrain barley β-glucan suppressed feed intake and increased cecal fermentation but did not improve postprandial glucose control or insulin sensitivity.

Keywords: Barley; Glycemic index; Incretin; SCFA; Satiety; Wholegrain; β-Glucan.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Glucose
  • Cecum / microbiology*
  • Diet, High-Fat / adverse effects*
  • Dietary Fiber / administration & dosage
  • Eating / drug effects*
  • Fermentation / drug effects*
  • Gastric Inhibitory Polypeptide / metabolism
  • Glucagon-Like Peptide 1 / metabolism
  • Glucose Tolerance Test
  • Hordeum / chemistry*
  • Insulin / blood
  • Male
  • Rats
  • Rats, Sprague-Dawley
  • beta-Glucans / administration & dosage
  • beta-Glucans / pharmacology*

Substances

  • Blood Glucose
  • Dietary Fiber
  • Insulin
  • beta-Glucans
  • Gastric Inhibitory Polypeptide
  • Glucagon-Like Peptide 1